Journal of Pioneering Medical Sciences10.61091/jpms202413516Research ArticleBio-effects of present of AL NPs in Different Vaccines on Hematology Analysis of Rabbit’s In-Vivo StudyYounisMohammed Abdul HameedRadhiMuhammed MizherIbrahimSuhaib KalidAnesthesia Techniques Dept.college of Health and Medical TechniquesBaghdadMiddle Technical University (MTU).Radiological Techniques Departmentcollege of Health and Medical Technology BaghdadMiddle Technical University (MTU).In present study aims to measure the effects of different types vaccines (polio, and BCG) and aluminum nanoparticles (AL NPs) at different concentrations (0.5 and 1M) on eight hematological parameters: White blood cells (WBCs), red blood cells (RBCs), hemoglobin (HGB), platelets (PLT), monocytes (MONO), granulocytes (GRANUL), hematocrit (HCT) and lymphocytes (LYMPHO). In the experimental twelve male rabbits in vivo non-randomized control trials were divided into four groups. Group control (n-6) and three groups injected with AL NPs (n-6) at different doses, BCG vaccine (n-6), and polio vaccine (n-6). The results after injected with AL NPs, BCG, and Polio vaccines with different doses and study the CBC analysis of all parameters are significant statistical analysis except for PLT values are non-significant. It seems from the results that the AL NPs has highly affected on the blood components and also, the both polio and BCG vaccines which have some percentage of nanoparticles of aluminum. The results of CBC analysis of blood mentioned the parameters analyzed are abnormal values that affected on the immune system of the animal. It can be concluded that the nanoparticles have been affected on the blood parameters, was long-duration more harmful and effect.AL NPsBCG vaccinepolio vaccinehematology analysisrabbits blood samples36202423720243082024This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.1. Introduction

One of the components of vaccines, especially those used for children, is aluminum, and it is scientifically known that the aluminum compound has toxicity in the blood. Based on the recommendations and warnings of the US Food and Drug Administration (FDA), these are the calculations for the amount of aluminum that is permissible to be injected in one go into the body [1-7]: A healthy infant weighing 3,600 kg takes 18 mcg of aluminum. A healthy infant weighing 6,800 kg takes 34 mcg A healthy baby weighing 13 kg absorbs 68 mcg A healthy baby weighing 22 kg absorbs 113 mcg An adult weighing 68 kg takes 340 mcg Aluminum amounts according to the dose of vaccinations Hib (pedVaxHib brand) 224mcg per shot. DTaP 170mcg to 625mcg depending on the manufacturer. pneumococcus 125 \(\mu\)g. Hepatitis A 250 mcg. HPV 225mcg. DTaP, HIB & Plio combo 330mcg. DTaP, Hep B & Polio combo 850mcg. BCG, a live vaccine strain of Mycobacterium bovis, is commonly used to prevent the prevalence and burden of tuberculosis (TB) but is not used in the United States due to the low prevalence of TB in the general population and the fact that BCG vaccine complicates the interpretation of skin tests for TB. However, OPV and BCG vaccine recipients who are in the United States as visitors or immigrants may present healthcare providers with complex medical problems related to vaccines other than those recommended by the CDC and the American Academy of Pediatrics, Case reports and cohort studies from several countries other than the United States show the continued incidence of iVDPVs and the need for continued monitoring [8]. The study focused specifically on vaccination coverage with Bacille de Calmette et Guérin (BCG), birth dose of oral polio vaccine (OPV zero dose). This study aimed to shed light on vaccination coverage at birth doses and factors associated with timely vaccination in the Budur health district. Timely administration of birth doses is a challenge in the Bodur Health District [9]. It is recommended that oral polio vaccine (OPV) be given at birth along with the BCG vaccine. OPV was not available during some periods and therefore some children did not receive OPV at birth, but only the Bacillus Calmette (BCG) vaccine. We investigated the effect of an oral vaccine given concomitantly with BCG at birth on the immune response to BCG. This study is the first to address the consequences of the immune response to BCG given concomitant administration with OPV. The results suggest that the common practice of administering the oral vaccine with BCG at birth may down regulate the response to BCG [10]. In this research, the aim is to achieve safety in the use of children’s vaccines free from nanoparticles that cause many problems in the blood components.

2. Materials and Methods

A. Hematological parameter Blood samples was collected via cardiac puncture by using 5ml disposable syringe, 2 ml of blood collected in heparinized tube for hematological parameters which were measured as soon as possible. The hematological tests were done By using hematology autoanalyser, (huma counts 5). Germany origin with serial number of 160247. The instrument measure and calculates 22 different parameters. The hematology autoanalyser containing four solutions (HC5-BASOLYSE contain cyanide free lyse reagent, HC-LYSECF containing cyanide free lyse reagent, HC5-EOLYSE containing cyanide free lyse reagent, and HC- cleaner cleaning solution used to clean fluidic system), and the instrument have a printer mechanic inside with thermal paper. The hematological parameters estimated by this instrument were (RBC, WBC, DWBC, Hb, PCV, and platelets count) [11,12]. B. Procedure Blood collecting in tubes containing an anticoagulants to prevent forming clots that will clog the cell count. Then position the sample tube in the sample rotor and press start key, The sample rotor turns in moving the sample inside the instrument and the needle draw (90 \(\mu\)l) of blood sample from the tube. The aspirating needle retracted after a few second the rotor turn again returning the blood sample tube after that we can remove the tube from adaptor of the rotor. The ends of analysis were displayed in screen, including all the measured and calculated parameters which are stored automatically in the memory without any operator confirmation. After that we can printing the results by pressing print key. C. Statistical analysis All statistical analyzes were performed using SPSS version 21 software and results were described as mean ± SD using one-way ANOVA and least significant differences (LSD) test for a between-group comparison study. As a final point, the statistical significance difference (probability value) was at the 0.05 level [13]. D. Preparation and Characterization of AL NPs The lyophilization method was used to convert the micro alum to nanoparticles by the lyophilizer apparatus shown in Figure 1. the AL NPs NPs was characterized by spectroscopic methods using field emission scanning electron microscopy (FESEM), atomic force microscopy (AFM), and Transmission electron microscopy (TEM) to confirm its conversion to nanoparticles as shown in Figures 2- 4 respectively. It was found from FESEM analysis of the morphology and dimension of nanoparticles of Alum NPs as shown in Figure 2, about 75.15 nm the dimension of AL NPs which included with nanoparticles size. also, the spherical form of AL NPs was shown in AFM analysis as shown in in Figure 3. Figure 1: Lyophylization instrument Figure 2: FESEM of Alum NPs Figure 3: AFM of Alum NPs Figure 4: TEM of Alum NPs  

3. Results and Discussion

Standard hematology markers were selected for analysis such as hemoglobin level (HGB), red blood cell (RBC), platelets (PLT), white blood cells (WBCs), lymphocyte (LYMPHO), granulocytes (GRANUL), monocyte (MONO), and hematocrit (HCT). The blood samples were received from rabbits that injected with AL NPs, polio vaccine, and BCG vaccine at different doses. A. Effects of AL NPs, BCG, and Polio vaccine at different doses on hematology analysis of rabbits blood Each of the vaccines (polio and BCG) and different doses of AL NPs (0.5 and 1 ml of 0.1M) were studied in experiments using rabbits in order to identify their effect on the blood composition through the necessary analyses of the blood of rabbits dosed with different vaccines and at different concentrations of AL NPs., by CBC analysis can be examined the rabbits blood at different parameters as in the following studies: B. Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology White blood cells (WBCs) The percentage of WBC in the blood of rabbits was analysed in different cases, where the value of the statistical mean was identified for the blood of rabbits that did not receive any of the vaccines or AL NPs (control group), and then compared the results with blood of rabbits dosed with polio and BCG vaccines and with AL NPs (1 and 2), positive results were found with the high significant for all cases as shown in Table 1, these mean that the vaccines (polio and BCG) and AL NPs at different concentrations were effected on the WBC values and in turn, it effects on the immunity of the animal [14]. As a result, a significant in the account of WBC in the vaccinated of animals was an indicator of stress-related consequences, and further research into the immunomodulatory effect on vaccinated rabbits was indicated. Since the development of leukocyte count showed tissue injury, and white blood cell disorders (leukemia), the effect of AL NPs or the nanoparticles contained in vaccines led to leukocytosis, which was then followed by lymphocytosis [15]. Table 1: Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology white blood cells (WBCs)   N Mean Std. Deviation Std. Error Range ANOVA test (P-value) Mini. Maxi. WBC Control     1 6 13.183 1.2576 .5134 11 14.5 2 6 13.667 1.8886 .7710 11 16.0 3 6 14.167 1.5055 .6146 12 16.0 4 6 13.00 1.414 .577 11 15 Total 24           WBC Polio   0.001 High Sign 1 6 .4167 .11325 .04624 .30 .60 2 6 5.4083 .58345 .23819 4.50 6.00 3 6 2.8850 .76115 .31074 2.00 .25 4 6 .4033 .12910 .05270 4.00 .60 Total 24           WBC BCG     0.000 High Sign 1 6 7.617 . 5419 .2212 7.0 8.5 2 6 2.333 . 3502 .1430 1.9 2.9 3 6 2.2683 .17440 .07120 2.00 2.50 4 6 .4067 .14236 .05812 .20 .60 Total 24           WBC ALNP1   0.000 High Sign 1 6 1.4650 .19532 .07974 1.20 1.70 2 6 1.3950 .14195 .05795 1.20 1.60 3 6 2.4517 . 30069 .12276 2.00 2.90 4 6 .4050 .14195 .05795 .20 .60 Total 24           WBC ALNP2   0.000 High Sign 1 6 .7650 .16538 .06752 .59 1.00 2 6 2.3533 .18403 .07513 2.10 2.60 3 6 1.3333 .21602 .08819 1.00 1.60 4 6 .7583 .18552 .07574 .50 1.00 Total 24           C. Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology red blood cells (RBCs) Table 2 illustrated the RBC values of the control group that comparing with other values of RBC of groups doses with vaccines and with AL NPs, it was observed the decreasing of RBC in these groups as shown in Table 2., so the effect of polio vaccine has less with significant than in other cases with high significant. The decrease of account of RBC that causes anemia disease [16]. RBCs was a target as the main and most affected by the nanoparticles. The interaction between RBC and the vaccines and AL NPs is very complex and involves several oxidative stress [17]. Table 2: Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology red blood cells (RBCs)   N Mean Std. Deviation Std. Error Range ANOVA test (P-value) Mini. Maxi. RBC Control     1 6 5.06 0.75 0.309 4 6 2 6 5.18 0.74 0.305 4 6 3 6 5.41 0.58 0.238 4.5 6 4 6 5.33 0.87 0.358 4 6.5 Total 24           RBC Polio   0.021 Sign 1 6 2.83 0.68 0.278 2 4 2 6 5.01 0.70 0.288 4 6 3 6 4.65 1.02 0.419 3 6 4 6 5.6 0.89 0.366 4.5 6.9 Total 24           RBC BCG     0.000 High Sign 1 6 1.25 0.68 0.281 0.50 2 2 6 4.21 0.88 0.360 3 5.3 3 6 2.68 0.75 0.308 2 4 4 6 4.56 0.97 0.397 3 6 Total 24           RBC ALNP1   0.002 High sign 1 6 3.03 0.68 0.278 2 4 2 6 5.1 1.43 0.585 3 7 3 6 7.11 1.42 0.583 5 9 4 6 3.55 1.007 0.411 2 5 Total 24           RBC ALNP2   0.002 High Sign 1 6 1.6 0.58 0.238 1 2.5 2 6 5.11 1.44 0.589 3 7 3 6 4.63 1.08 0.444 3 6 4 6 6.76 1.14 0.466 5 8 Total 24           D. Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology hemoglobin HGB There has been a change in the value of hemoglobin (HGB) in the blood of rabbits in each of the AL NPs at different concentrations, as they are increased in HGB values compared with their in the vaccines value when compared with the control group as shown in Table 3. So, it was found a high significant statistical study [18]. The changes in blood parameters of CBC analysis especially in HGB values may be caused by oxidative stress, leading to uncontrolled hemoglobin test, which can lead to anemia and bone marrow suppression, as well as an increase in the hematopoietic function of the bone marrow. This theory can also be applied to other conditions of erythrocyte malformation [19]. Table 3: Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology hemoglobin (HGB)   N Mean Std. Deviation Std. Error Range ANOVA test (P-value) Mini. Maxi. HGB Control     1 6 10.300 0.5692 0.2324 9.5 11.0 2 6 9.467 1.1928 0.4869 7.4 10.9 3 6 9.600 0.7874 0.3215 9.0 11.0 4 6 9.900 0.6693 0.2733 9.0 11.0 Total 24           HGB Polio   0.000 High sign 1 6 9.917 0.7910 0.3229 9.0 11.0 2 6 10.583 1.0206 0.4167 9.0 12.0 3 6 10.917 0.9704 0.3962 9.5 12.0 4 6 10.200 0.8343 0.3406 9.0 11.1 Total 24           HGB BCG     0.003 sign 1 6 10.1 0.8 0.170 9.0 11.0 2 6 10.75 0.935 0.187 9.50 12.0 3 6 7.983 1.897 0.335 5.40 10.5 4 6 10.516 0.884 0.205 9.50 12.0 Total 24           HGB ALNP1   0.000 High Sign 1 6 13.05 0.71 0.292 12 14 2 6 11.98 0.70 0.289 11 13 3 6 13.48 0.88 0.214 12 14.5 4 6 8.25 0.52 0.407 7.5 9 Total 24           HGB ALNP2   0.000 High Sign 1 6 11.96 0.711 0.290 11 13 2 6 12.43 0.86 0.352 11 13.5 3 6 10.43 0.72 0.296 9.5 11.5 4 6 17.30 0.59 0.243 16.5 18 Total 24           E. Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology platelets (PLT) A platelet (PLT) count is a type of test that measures the number of platelets in the blood. Platelets are used by the body in the process of blood clotting. A decrease in the number of platelets in the blood can be a sign of cancer, infection, or various health problems. It may be suffer from blood clots or a stroke if their number of PLT in blood decreases [20]. In this study Table 3 illustrated the effect of the account of platelets with different vaccines and AL NPs at different concentrations, the control group indicted with lower account of PLT comparing with high values of the PLT of the blood samples doses with different vaccines and with AL NPs, so the results in Table 4 show non-significant in statistical analysis for all groups. It has been shown from these results that there are direct positive effects on blood composition when using different vaccines and AL NPs [21]. Table 4: Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology platelets (PLT)   N Mean Std. Deviation Std. Error Range ANOVA test (P-value) Mini. Maxi. PLT Control     1 6 342.5 13.32 5.439 325 360 2 6 344.16 12.00 4.901 325 360 3 6 342.5 13.32 5.439 325 360 4 6 342.5 13.32 5.439 325 360 Total 24           PLT Polio   0.986 Non Sign 1 6 1758.33 115.83 47.28 1600 1900 2 6 1001.16 69.65 28.43 900 1100 3 6 138.83 16.005 6.53 120 160 4 6 27 15.93 6.50 10 50 Total 24           PLT BCG     0.797 Non Sign 1 6 1357 33.43 13.65 1300 1400 2 6 186.33 12.11 4.94 170 200 3 6 296.33 18.56 7.57 270 320 4 6 28.5 14.61 5.96 10 50 Total 24           PLT ALNP1   0.507 Non Sign 1 6 2488.33 266.86 108.94 2000 2700 2 6 46.83 16.12 6.58 30 70 3 6 293 17.37 7.09 270 320 4 6 95.16 10.40 4.24 80 110 Total 24           PLT ALNP2   0.906 Non Sign 1 6 1008.83 80.05 32.68 900 1100 2 6 928.66 20.46 8.35 900 950 3 6 36.5 16.53 6.75 19 60 4 6 67.16 11.10 4.53 50 80 Total 24           F. Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology lymphocyte (LYMPHO) Lymphocytes (LYMPHO) are one of the types of white blood cell. It helps the immune system to defend against to different diseases such as cancer, viruses and various bacteria by measuring the number of LYMPHO. Lymphocyte levels vary with age, race, sex, height, and lifestyle [22]. Table 5 shows the values of LYMPHO in the control group and other groups doses with different vaccines and AL NPs at different concentrations, which shows the high significant values of all groups. Table 5: Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology lymphocyte (LYMPHO)   N Mean Std. Deviation Std. Error Range ANOVA test (P-value) Mini. Maxi. LYMPHO Control     1 6 3.81 0.604 0.270 3 4.6 2 6 3.23 0.394 0.176 2.5 3.6 3 6 2.5 0.294 0.131 2 3 4 6 2.75 0.170 0.076 2.5 3 Total 24           LYMPHO Polio   0.000 High Sign 1 6 2.08 0.134 0.060 1.9 2.3 2 6 2.25 0.170 0.763 2 2.5 3 6 1.33 0.195 0.087 1 1.6 4 6 1.11 0.13 0.060 0.9 1.3 Total 24           LYMPHO BCG     0.000 High Sign 1 6 5.55 0.18 0.076 5.3 5.8 2 6 1.83 1.16 0.066 1.6 2 3 6 0.83 0.14 0.060 0.6 1 4 6 0.8 0.14 0.057 0.6 1 Total 24           LYMPHO ALNP1   0.000 High Sig 1 6 1.26 0.169 0.075 1 1.5 2 6 1.27 0.158 0.070 1 1.5 3 6 1.39 0.131 0.058 1.2 1.6 4 6 1.4 0.129 0.057 1.2 1.6 Total 24           LYMPHO ALNP2   0.000 High Sign 1 6 0.26 0.149 0.066 0.10 0.50 2 6 1.66 0.177 0.079 1.40 1.90 3 6 0.69 0.129 0.058 0.50 0.90 4 6 0.1 0 0.000 0.10 0.10 Total 24           G. Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology monocyte (MONO) A type of white blood cell in the immune system is monocyte (MONO), these cells may be kill the invader cell or alert other blood cells to help destroy it and prevent infection [23]. Table 6 illustrated the MONO analysis decreased values were observed when administering vaccines to rabbits Table 6: Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology monocyte (MONO)   N Mean Std. Deviation Std. Error Range ANOVA test (P-value) Mini. Maxi. MONO Control     1 6 5.49 0.344 0.153 5 6 2 6 5.033 0.926 0.414 3.5 5.9 3 6 4.25 0.403 0.180 3.4 4.6 4 6 4.76 0.179 0.080 4.5 5 Total 24           MONO Polio   0.000 High Sign 1 6 1.66 0.149 0.066 1.5 1.9 2 6 1.48 0.226 0.101 1.2 1.9 3 6 0.42 0.140 0.062 0.2 0.6 4 6 0.59 0.146 0.065 0.4 0.8 Total 24           MONO BCG     0.000 High Sing 1 6 0.60 0.14 0.057 0.4 0.8 2 6 0.56 0.30 0.124 0.07 0.9 3 6 0.75 0.18 0.076 0.5 1 4 6 0.75 0.18 0.076 0.5 1 Total 24           MONO ALNP1   0.000 High Sing 1 6 0.041 0.013 0.006 0.02 0.06 2 6 0.07 0.013 0.006 0.05 0.09 3 6 0.55 0.171 0.076 0.3 0.8 4 6 0.71 0.154 0.068 0.5 0.99 Total 24           MONO ALNP2   0.000 High Sing 1 6 0.1 0 0.000 0.10 0.10 2 6 0.21 0.106 0.047 0.10 0.40 3 6 0.25 0.094 0.042 0.10 0.40 4 6 0.1 0 0.000 0.10 0.10 Total 24           H. Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology granulocytes (GRANUL) Granule cells or granulocytes (GRANUL) are one of the most well-known types of white blood cells. They are small granules that secrete enzymes when the immune system is exposed to disease. These GRANUL cells happens during the occurrence of disease infection. Granulocytes are produced from stem cells in the bone marrow and only live for a few days [24]. Such an analysis of GRANUL is important to know the effect of vaccines on the immune system through these test, in Table 7 shows a dropping of the GRANUL values than in normal group (control) this decreasing of GRANUL after doses the rabbits with vaccines and AL NPs effected on the immune system, the all cases have high significant as shown in Table 7. Table 7: Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology granulocytes (GRANUL)   N Mean Std. Deviation Std. Error Range ANOVA test (P-value) Mini. Maxi. GRANUL Control     1 6 4.71 0.13 0.060 4.5 4.9 2 6 5.33 0.19 0.088 5 5.6 3 6 3.75 0.17 0.076 3.5 4 4 6 4.38 0.24 0.107 4 4.7 Total 24           GRANUL Polio   0.000 High Sign 1 6 1.41 0.13 0.060 1.2 1.6 2 6 1.65 0.17 0.076 1.4 1.9 3 6 0.42 0.13 0.062 0.2 0.6 4 6 0.75 0.17 0.076 0.5 1 Total 24           GRANUL BCG     0.000 High Sign 1 6 2.33 0.163 0.066 2.10 2.50 2 6 0.22 0.113 0.046 0.10 0.40 3 6 0.68 0.146 0.059 0.50 0.90 4 6 0.68 0.147 0.060 0.50 0.90 Total 24           GRANUL ALNP1   0.000 High Sign 1 6 0.22 0.107 0.048 0.10 0.4 2 6 0.06 0.017 0.007 0.04 0.09 3 6 0.39 0.129 0.058 0.20 0.6 4 6 0.38 0.134 0.060 0.20 0.6 Total 24           GRANUL ALNP2   0.000 High Sign 1 6 0.1 0 0.000 0.10 0.10 2 6 0.20 0.08 0.037 0.10 0.30 3 6 0.16 0.04 0.018 0.10 0.33 4 6 0.01 0 0.000 0.01 0.01 Total 24           I. Effect of AL NPs, Polio vaccine, and BCG vaccine on hematology of hematocrit (HCT) Hematocrit (HCT) or the volume of stacked cells, scientifically meaning hematocrit, is the process of separation of blood, as well as it is measured by calculating the percentage of the volume of red blood cells from the total volume of blood. As for the normal values in human, it is 47% for men and 42% for women and for children, it is about 36% to 44% [25]. Table 8 shows the statistical calculation of the means values of HCT between the control group and mean values of different blood samples of the rabbits doses with polio, BCG vaccines and AL NPs, it was found the P-value for all cases have high significant, so the effect of vaccine and AL NPs on the rabbits blood is clear by increasing the values of HCT. Table 8: Effect of AL NPs, Polio vaccine, and BCG vaccine on hematocrit (HCT)   N Mean Std. Deviation Std. Error Range ANOVA test (P-value) Mini. Maxi. HCT Control     1 6 35.033 0.86 0.352 34 36 2 6 35.183 0.74 0.305 34 36 3 6 35.666 1.75 0.714 33 38 4 6 34.66 1.84 0.75 33 37 Total 24           HCT Polio   0.000 High Sign 1 6 13.98 1.281 0.523 12 15.4 2 6 36.55 1.065 0.434 35 37.8 3 6 36.85 1.137 0.464 35 38 4 6 35.93 0.816 0.333 35 37 Total 24           HCT BCG     0.000 High Sign 1 6 4.083 1.744 0.712 2 6.5 2 6 41.2 1.104 0.45 40 43 3 6 16.1 4.913 2.00 10 22 4 6 33.016 4.737 1.03 25 38 Total 24           HCT ALNP1   0.000 High Sign 1 6 13.85 0.99 0.407 12 15 2 6 41.26 1.08 0.442 40 43 3 6 50.41 7.14 2.91 40 60 4 6 27.58 4.52 1.845 20 33 Total 24           HCT ALNP2   0.000 High Sign 1 6 7.66 0.57 0.234 7 8.5 2 6 43.36 0.94 0.384 42 44.5 3 6 30.95 3.52 1.440 25 35 4 6 58.2 9.28 3.791 45 70 Total 24           Figure 5 illustrated the relationship between the mean values of each control, polio vaccine, BCG vaccine, and AL NPs at 0.5, and 1 M which injected the rabbits to examine their blood of CBC analysis of each WBC, LYMPHO, MONO, and GRANUL, Fig.6 for each HCT, HGB, and RBC. The results of these study observed that all CBC analysis of blood samples have abnormal results with significant statistical analysis except the PLT analysis has non-significant, so the results in the Fig. 5, and 6 has a homogenous in consequence, and have the effected on the blood components [26]. Figure 5: Relationship between the mean values of each control, polio vaccine, BCG vaccine, and AL NPs at 0.5, and 1 M, for CBC analysis of WBC, LYMPHO, MONO, and GRANUL Figure 6: Relationship between the mean values of each control, polio vaccine, BCG vaccine, and AL NPs at 0.5, and 1 M, for CBC analysis of HCT, HGB, and RBC

4. Conclusion

It is possible to conclude from the this research several important matters of concern to the health and life of children in particular by identifying the effects resulting from the use of some chemicals, especially AL NPs. The results were monitored in this research through a complete blood analysis (CBC) and obtained the following: each of polio, BCG vaccines, and AL NPs were effected on the blood components of rabbits doses with these vaccines and nanoparticles by the CBC analysis. all of the CBC analysis of blood samples tested of White blood cells (WBCs), red blood cells (RBCs), hemoglobin (HGB), platelets (PLT), monocytes (MONO), granule (GRANUL), hematocrit (HCT) and lymphocytes (LYMPHO) which effected with high significant statistical analysis except of PLT value that has non-significant. all factors in CBC analysis mentioned to the effect the immune system with the vaccines and AL NPs. the safest method that can be achieved to obtain healthy vaccines and not affect them in the future on the health of children is to be avoided the use of nanomaterial in vaccines in order to prevent harm

Conflict of Interest

The authors declare no conflict of interests. All authors read and approved final version of the paper.

Authors Contribution

All authors contributed equally in this paper.

ReferencesAlghriany, A. A., Omar, H. E., Mahmoud, A. M., & Atia, M. M. (2022). Assessment of the toxicity of aluminum oxide and its nanoparticles in the bone marrow and liver of male mice: Ameliorative efficacy of curcumin nanoparticles. ACS Omega, 7(16), 13841-13852.O’Malley, K. J., Bowling, J. L., Stinson, E., Cole, K. S., Mann, B. J., Namjoshi, P., et al. (2018). Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis. PLoS ONE, 13(10).Planty, C., Chevalier, G., Duclos, M. E., Chalmey, C., Thirion-Delalande, C., & Sobry, C. (2020). Nonclinical safety assessment of repeated administration and biodistribution of ChAd3-EBO-Z Ebola candidate vaccine. Journal of Applied Toxicology, 40(6), 748-762.Ledesma-Feliciano, C., Chapman, R., Hooper, J. W., Elma, K., Zehrung, D., et al. (2023). Improved DNA vaccine delivery with needle-free injection systems. Vaccines, 11(2), 280.FDA. (n.d.). Code of Federal Regulations Title 21. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/CFRSearch.cfm?fr=201.323Committee on Nutrition, American Academy of Pediatrics. (1996). Aluminum toxicity in infants and children. Pediatrics, 97(3), 413-416.Radhi, M. M., Tan, W. T., Ab Rahman, M. Z. B., & Kassim, A. B. (2010). Electrochemical characterization of the redox couple of [Fe(CN)\(_6\)]\(^{3-}\)/[Fe(CN)\(_6\)]\(^{4-}\) mediated by a grafted polymer modified glassy carbon electrode. Journal of Chemical Engineering of Japan, 43(11), 927-931.Trimble, R., Atkins, J., Quigg, T. C., Burns, C. C., Wallace, G. S., Thomas, M., et al. (2014). Vaccine-associated paralytic poliomyelitis and BCG-osis in an immigrant child with severe combined immunodeficiency syndrome—Texas, 2013. Morbidity and Mortality Weekly Report, 63(33), 721.Bassoum, O., Sougou, N. M., Ba, M. F., Anne, M., Bocoum, M., Dieye, A., et al. (2022). Vaccination against tuberculosis, polio and hepatitis B at birth in Podor health district, Northern Senegal: Cross-sectional study of vaccination coverage and its associated factors. BMC Public Health, 22(1), 1-3.Sartono, E., Lisse, I. M., Terveer, E. M., van de Sande, P. J., Whittle, H., Fisker, A. B., et al. (2010). Oral polio vaccine influences the immune response to BCG vaccination: A natural experiment. PLoS ONE, 5(5), e10328.de Gonzalo-Calvo, D., Barroeta, I., Nan, M. N., Rives, J., Garzón, D., Carmona-Iragui, M., et al. (2020). Evaluation of biochemical and hematological parameters in adults with Down syndrome. Scientific Reports, 10(1), 13755.Rokohl, A. C., & Heindl, L. M. (2021). Effective systemic treatment of advanced periocular basal cell carcinoma with sonidegib. Graefe’s Archive for Clinical and Experimental Ophthalmology, 259, 3821-3822.Whitbread, T. J. (2015). Clinical Hematology. Medically Reviewed.Lu, Y., Fang, J. Q., Tian, L., & Jin, H. (2015). Advanced Medical Statistics (Vol. 5). World Scientific.Ibraheim, M. H., Hanafy, M. S., & Nassar, S. A. (2020). Effects of radiofrequency radiation emitted from mobile phones on hematological parameters in albino mice. Arab Journal of Nuclear Sciences and Applications, 53(3), 189-196.Noor, E. S., Wan, S. W., Norazureen, N., & Qalidah, M. A. (n.d.). Effects of 2.45 GHz microwave radiation on hematological changes of Sprague-Dawley rats with red palm oil consumption.Smith Jr., R. E. (2010). The clinical and economic burden of anemia. American Journal of Managed Care, 16(Suppl Issues), S59-S66.Sartono, E., Lisse, I. M., Terveer, E. M., van de Sande, P. J., Whittle, H., Fisker, A. B., et al. (2010). Oral polio vaccine influences the immune response to BCG vaccination: A natural experiment. PLoS ONE, 5(5), e10328.Revin, V. V., Gromova, N. V., Revina, E. S., Samonova, A. Y., Tychkov, A. Y., Bochkareva, S. S., et al. (2019). The influence of oxidative stress and natural antioxidants on morphometric parameters of red blood cells, the hemoglobin oxygen-binding capacity, and the activity of antioxidant enzymes. BioMed Research International, 2019.Mumford, J., Flanagan, B., Keber, B., & Lam, L. (2019). Hematologic conditions: Platelet disorders. FP Essentials, 485, 32-43.Krishnegowda, M., & Rajashekaraiah, V. (2015). Platelet disorders: An overview. Blood Coagulation & Fibrinolysis, 26(5), 479-491.Adkinson Jr., N. F. (2008). Middleton’s Allergy: Principles and Practice (2-Volume Set). Elsevier Health Sciences.Brian, K., & Ingram, D. A. (2015). Clinical significance of monocyte heterogeneity. Clinical and Translational Medicine, 4, 5.Melillo, A. (2007). Rabbit clinical pathology. Journal of Exotic Pet Medicine, 16(3), 135-145.Breedveld, A., Groot Kormelink, T., van Egmond, M., & de Jong, E. C. (2017). Granulocytes as modulators of dendritic cell function. Journal of Leukocyte Biology, 102(4), 1003-1016.Lipowsky, H. H., Usami, S., Chien, S., & Pittman, R. N. (1982). Hematocrit determination in small bore tubes by differential spectrophotometry. Microvascular Research, 24(1), 42-55.